Michael D. Wendt.Protein-Protein Interactions as Drug Targets.Shaomeng Wang ,Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar.Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics .Kurt Deshayes , Jeremy Murray , Domagoj Vucic.The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer .John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto.Protein-Protein Interaction Targets to Inhibit HIV-1 Infection .Nicholas A. Meanwell , David R. Langley.Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus .Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora.Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces .Michael D. Wendt.The Discovery of Navitoclax, a Bcl-2 Family Inhibitor. . INDICE: Protein-Protein Interactions as Drug Targets.- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics.- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer.- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection.- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus.- Rational Design Strategies for Developing Synthetic Inhibitors of HelicalProtein Interfaces.- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.
- ISBN: 978-3-642-28964-4
- Editorial: Springer
- Encuadernacion: Cartoné
- Fecha Publicación: 30/06/2012
- Nº Volúmenes: 1
- Idioma: Inglés